492 related articles for article (PubMed ID: 25645594)
1. Stem cells for amyotrophic lateral sclerosis modeling and therapy: myth or fact?
Coatti GC; Beccari MS; Olávio TR; Mitne-Neto M; Okamoto OK; Zatz M
Cytometry A; 2015 Mar; 87(3):197-211. PubMed ID: 25645594
[TBL] [Abstract][Full Text] [Related]
2. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
Liu Y; Deng W
Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
[TBL] [Abstract][Full Text] [Related]
3. Cellular and molecular approaches to motor neuron therapy in amyotrophic lateral sclerosis and spinal muscular atrophy.
O'Connor DM; Boulis NM
Neurosci Lett; 2012 Oct; 527(2):78-84. PubMed ID: 22579818
[TBL] [Abstract][Full Text] [Related]
4. Stem cell therapy in amyotrophic lateral sclerosis.
Meamar R; Nasr-Esfahani MH; Mousavi SA; Basiri K
J Clin Neurosci; 2013 Dec; 20(12):1659-63. PubMed ID: 24148693
[TBL] [Abstract][Full Text] [Related]
5. Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis: Results of Phase 1/2 and 2a Clinical Trials.
Petrou P; Gothelf Y; Argov Z; Gotkine M; Levy YS; Kassis I; Vaknin-Dembinsky A; Ben-Hur T; Offen D; Abramsky O; Melamed E; Karussis D
JAMA Neurol; 2016 Mar; 73(3):337-44. PubMed ID: 26751635
[TBL] [Abstract][Full Text] [Related]
6. Intraspinal stem cell transplantation for amyotrophic lateral sclerosis.
Chen KS; Sakowski SA; Feldman EL
Ann Neurol; 2016 Mar; 79(3):342-53. PubMed ID: 26696091
[TBL] [Abstract][Full Text] [Related]
7. Modelling and treating amyotrophic lateral sclerosis through induced-pluripotent stem cells technology.
Bohl D; Pochet R; Mitrecic D; Nicaise C
Curr Stem Cell Res Ther; 2016; 11(4):301-12. PubMed ID: 26018231
[TBL] [Abstract][Full Text] [Related]
8. Stem cell transplantation for amyotrophic lateral sclerosis: therapeutic potential and perspectives on clinical translation.
Faravelli I; Riboldi G; Nizzardo M; Simone C; Zanetta C; Bresolin N; Comi GP; Corti S
Cell Mol Life Sci; 2014 Sep; 71(17):3257-68. PubMed ID: 24699704
[TBL] [Abstract][Full Text] [Related]
9. Phase I trial of repeated intrathecal autologous bone marrow-derived mesenchymal stromal cells in amyotrophic lateral sclerosis.
Oh KW; Moon C; Kim HY; Oh SI; Park J; Lee JH; Chang IY; Kim KS; Kim SH
Stem Cells Transl Med; 2015 Jun; 4(6):590-7. PubMed ID: 25934946
[TBL] [Abstract][Full Text] [Related]
10. Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model.
Nizzardo M; Simone C; Rizzo F; Ruggieri M; Salani S; Riboldi G; Faravelli I; Zanetta C; Bresolin N; Comi GP; Corti S
Hum Mol Genet; 2014 Jan; 23(2):342-54. PubMed ID: 24006477
[TBL] [Abstract][Full Text] [Related]
11. Advances in stem cell research for Amyotrophic Lateral Sclerosis.
Papadeas ST; Maragakis NJ
Curr Opin Biotechnol; 2009 Oct; 20(5):545-51. PubMed ID: 19819686
[TBL] [Abstract][Full Text] [Related]
12. Stem cells in amyotrophic lateral sclerosis: motor neuron protection or replacement?
Silani V; Calzarossa C; Cova L; Ticozzi N
CNS Neurol Disord Drug Targets; 2010 Jul; 9(3):314-24. PubMed ID: 20406179
[TBL] [Abstract][Full Text] [Related]
13. Biological markers of mesenchymal stromal cells as predictors of response to autologous stem cell transplantation in patients with amyotrophic lateral sclerosis: an investigator-initiated trial and in vivo study.
Kim HY; Kim H; Oh KW; Oh SI; Koh SH; Baik W; Noh MY; Kim KS; Kim SH
Stem Cells; 2014 Oct; 32(10):2724-31. PubMed ID: 24966156
[TBL] [Abstract][Full Text] [Related]
14. Neural stem cell-based treatment for neurodegenerative diseases.
Kim SU; Lee HJ; Kim YB
Neuropathology; 2013 Oct; 33(5):491-504. PubMed ID: 23384285
[TBL] [Abstract][Full Text] [Related]
15. Translational stem cell therapy for amyotrophic lateral sclerosis.
Boulis NM; Federici T; Glass JD; Lunn JS; Sakowski SA; Feldman EL
Nat Rev Neurol; 2011 Dec; 8(3):172-6. PubMed ID: 22158518
[TBL] [Abstract][Full Text] [Related]
16. Distribution, differentiation, and survival of intravenously administered neural stem cells in a rat model of amyotrophic lateral sclerosis.
Mitrecić D; Nicaise C; Gajović S; Pochet R
Cell Transplant; 2010; 19(5):537-48. PubMed ID: 20350352
[TBL] [Abstract][Full Text] [Related]
17. The past, present and future of stem cell clinical trials for ALS.
Thomsen GM; Gowing G; Svendsen S; Svendsen CN
Exp Neurol; 2014 Dec; 262 Pt B():127-37. PubMed ID: 24613827
[TBL] [Abstract][Full Text] [Related]
18. Stem cells therapy for ALS.
Mazzini L; Vescovi A; Cantello R; Gelati M; Vercelli A
Expert Opin Biol Ther; 2016; 16(2):187-99. PubMed ID: 26558293
[TBL] [Abstract][Full Text] [Related]
19. Stem cell transplantation for amyotrophic lateral sclerosis.
Baloh RH; Glass JD; Svendsen CN
Curr Opin Neurol; 2018 Oct; 31(5):655-661. PubMed ID: 30080719
[TBL] [Abstract][Full Text] [Related]
20. iPSC-derived LewisX+CXCR4+β1-integrin+ neural stem cells improve the amyotrophic lateral sclerosis phenotype by preserving motor neurons and muscle innervation in human and rodent models.
Nizzardo M; Bucchia M; Ramirez A; Trombetta E; Bresolin N; Comi GP; Corti S
Hum Mol Genet; 2016 Aug; 25(15):3152-3163. PubMed ID: 27270413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
